^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    ladiratuzumab vedotin (SGN-LIV1A)

    i
    Company:
    Merck (MSD), Pfizer
    Drug class:
    Microtubule inhibitor, LIV-1-targeted antibody-drug conjugate
    Related drugs: